Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicensePlus Black IconRevocationPlus Black IconReissuePlus Black IconCorrected translationPlus Black IconSPC

EP2396005

SGLT2 hindri til að bæta blóðsykursstjórn

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    11.2.2010
  • EP published:
    26.11.2025
  • EP application number:
    10703287.2
  • Max expiry date:
    10.2.2030
  • Expiry date:
    10.2.2027
  • Next due date:
    28.2.2027
  • Title in English:
    SGLT2 inhibitor for improving glycemic control
  • Language of the patent:
    English

Timeline

Today
11.2.2010EP application
26.11.2025EP Publication
30.1.2026Translation submitted
11.2.2026Registration published
10.2.2027Expires

Owner

  • Name:
    Boehringer Ingelheim International GmbH
  • Address:
    Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

  • Name:
    EICKELMANN, Peter
  • Address:
    55216 Ingelheim Am Rhein, DE
  • Name:
    MARK, Michael
  • Address:
    55216 Ingelheim Am Rhein, DE
  • Name:
    SEMAN, Leo John
  • Address:
    Ridgefield, CT 06877, US
  • Name:
    THOMAS, Leo
  • Address:
    55216 Ingelheim Am Rhein, DE
  • Name:
    BROEDL, Uli
  • Address:
    55216 Ingelheim Am Rhein, DE
  • Name:
    GREMPLER, Rolf
  • Address:
    55216 Ingelheim Am Rhein, DE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    152318 P
  • Date:
    13.2.2009
  • Country:
    US

Classification

  • Categories:
    A61K 31/7048, A61P 3/10

Annual fees

Number

Paid

Expires

Payer

Number: 17

Paid: 16.2.2026

Expires: 10.2.2027

Payer: G.H. Sigurgeirsson ehf.

Upload documents